FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

P J M Bakker

Research Profile

Disorders

Geographic Areas

Netherlands

Chemicals & Drugs

Procedures

Anatomy

Tumor Cells, Cultured

Concepts & Ideas

Physiology

Cell Divisions

Co-author Network

Publications

TOP 3
Maud M Geenen; P J M Bakker; leontien c kremer; J J P Kastelein; F E van Leeuwen
Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy.
Remko van der Togt; Erik Jan van Lieshout; Reinout Hensbroek; E Beinat; J M Binnekade; P J M Bakker
Electromagnetic interference from radio frequency identification inducing potentially hazardous incidents in critical care medical equipment.
G M Edward; S F Das; Sylvia G Elkhuizen; P J M Bakker; J A M Hontelez; Markus W Hollmann; Benedikt Preckel; Lucienne C Lemaire
Simulation to analyse planning difficulties at the preoperative assessment clinic.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of P J M Bakker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Maud M Geenen; P J M Bakker; leontien c kremer; J J P Kastelein; F E van Leeuwen
Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy.
Pediatric blood & cancer 2010;55(4):690-7.
2008: Remko van der Togt; Erik Jan van Lieshout; Reinout Hensbroek; E Beinat; J M Binnekade; P J M Bakker
Electromagnetic interference from radio frequency identification inducing potentially hazardous incidents in critical care medical equipment.
JAMA : the journal of the American Medical Association 2008;299(24):2884-90.
2008: G M Edward; S F Das; Sylvia G Elkhuizen; P J M Bakker; J A M Hontelez; Markus W Hollmann; Benedikt Preckel; Lucienne C Lemaire
Simulation to analyse planning difficulties at the preoperative assessment clinic.
British journal of anaesthesia 2008;100(2):195-202.
2007: Sylvia G Elkhuizen; S F Das; P J M Bakker; J A M Hontelez
Using computer simulation to reduce access time for outpatient departments.
Quality & safety in health care 2007;16(5):382-6.
2007: Maud M Geenen; Mathilde C Cardous-Ubbink; leontien c kremer; Cor van den Bos; H J H van der Pal; Richard C Heinen; M W M Jaspers; Caro C E Koning; Foppe Oldenburger; Nelia E Langeveld; Augustinus A M Hart; P J M Bakker; Huib N Caron; Flora E van Leeuwen
Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.
JAMA : the journal of the American Medical Association 2007;297(24):2705-15.
2007: Sylvia G Elkhuizen; M P M Burger; Rene E Jonkers; Martien Limburg; Niek S Klazinga; P J M Bakker
Using business process redesign to reduce wait times at a university hospital in the Netherlands.
Joint Commission journal on quality and patient safety / Joint Commission Resources 2007;33(6):332-41.
2007: M W M Jaspers; Cor van den Bos; Richard Heinen; P J M Bakker; Maud M Geenen; leontien c kremer; F van Leeuwen; Huib N Caron
Development of a national protocol to screen Dutch cancer survivors on late cancer treatment effects.
International journal of medical informatics 2007;76(4):297-305.
2007: Sylvia G Elkhuizen; Gert Bor; Marjolein Smeenk; Niek S Klazinga; P J M Bakker
Capacity management of nursing staff as a vehicle for organizational improvement.
BMC health services research 2007;7():196.
2007: Sylvia G Elkhuizen; Jasper R C van Sambeek; Erwin W Hans; Koos J J Krabbendam; P J M Bakker
Applying the variety reduction principle to management of ancillary services.
Health care management review 2007;32(1):37-45.
2007: Mathilde C Cardous-Ubbink; Richard Heinen; P J M Bakker; H van den Berg; Foppe Oldenburger; Huib N Caron; Paul A Voûte; Flora E van Leeuwen
Risk of second malignancies in long-term survivors of childhood cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(2):351-62.
2007: André B P van Kuilenburg; Heinz-Josef Klumpen; Anneke M Westermann; Lida Zoetekouw; Henk Van Lenthe; P J M Bakker; Dick J Richel; Henk-Jan Guchelaar
Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin.
European journal of cancer (Oxford, England : 1990) 2007;43(2):459-65.
2006: Sylvia G Elkhuizen; Martien Limburg; P J M Bakker; Niek S Klazinga
Evidence-based re-engineering: re-engineering the evidence--a systematic review of the literature on business process redesign (BPR) in hospital care.
International journal of health care quality assurance incorporating Leadership in health services 2006;19(6-7):477-99.
2005: H J H van der Pal; Elvira C van Dalen; leontien c kremer; P J M Bakker; Flora E van Leeuwen
Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review.
Cancer treatment reviews 2005;31(3):173-85.
2004: Mathilde C Cardous-Ubbink; Richard Heinen; Nelia E Langeveld; P J M Bakker; Paul A Voûte; Huib N Caron; Flora E van Leeuwen
Long-term cause-specific mortality among five-year survivors of childhood cancer.
Pediatric blood & cancer 2004;42(7):563-73.
2004: Eus J W van Someren; J Swart-Heikens; Erik Endert; Peter H Bisschop; Dick F Swaab; P J M Bakker; Johannes A Romijn; Eric Fliers
Long-term effects of cranial irradiation for childhood malignancy on sleep in adulthood.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(4):503-10.
2004: Elvira C van Dalen; H J H van der Pal; P J M Bakker; Huib N Caron; leontien c kremer
Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.
European journal of cancer (Oxford, England : 1990) 2004;40(5):643-52.
2004: CG Koedoot; Frans J Oort; Rob J De Haan; P J M Bakker; Alexander de Graeff; J C J M de Haes
The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting.
European journal of cancer (Oxford, England : 1990) 2004;40(2):225-35.
2003: CG Koedoot; Rob J De Haan; A M Stiggelbout; Peep F M Stalmeier; Alexander de Graeff; P J M Bakker; J C J M de Haes
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.
British journal of cancer 2003;89(12):2219-26.
2002: CG Koedoot; J C J M de Haes; Siem H Heisterkamp; P J M Bakker; Alexander de Graeff; Rob J De Haan
Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3658-64.
2000: M W M Jaspers; Huib N Caron; H Behrendt; Cor van den Bos; P J M Bakker; F van Leeuwen
The development of a new information model for a pediatric cancer registry on late treatment sequelae in The Netherlands.
Studies in health technology and informatics 2000;77():895-9.
1998: Robert Poorter; P J M Bakker; Cindy Veenhof
Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.
Pharmacy world & science : PWS 1998;20(2):45-59.
1998: André B P van Kuilenburg; Robert Poorter; Godefridus J Peters; Albert H van Gennip; Henk Van Lenthe; Alida E M Stroomer; Kees Smid; Paul Noordhuis; P J M Bakker; Cindy Veenhof
No circadian variation of dihydropyrimidine dehydrogenase, uridine phosphorylase, beta-alanine, and 5-fluorouracil during continuous infusion of 5-fluorouracil.
Advances in experimental medicine and biology 1998;431():811-6.
1997: P H J Frissen; Frank de Wolf; Peter Reiss; P J M Bakker; Cindy Veenhof; Sven A Danner; Jaap Goudsmit; Joep M A Lange
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma.
The Journal of infectious diseases 1997;176(3):811-4.
1997: Leonie J Rijks; P J M Bakker; Geertjan van Tienhoven; LA Noorduyn; GJ Boer; RC Rietbroek; Carlo W Taat; Anton G M Janssen; Cindy Veenhof; EA van Royen
Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2536-45.
1997: RC Rietbroek; P J van de Vaart; Jaap Haveman; F A Blommaert; AG Geerdink; P J M Bakker; Cindy Veenhof
Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.
Journal of cancer research and clinical oncology 1997;123(1):6-12.
1997: manon huizing; G Giaccone; LJ van Warmerdam; Hilde Rosing; P J M Bakker; Jan B Vermorken; P E Postmus; nico van zandwijk; M G Koolen; Wim W ten Bokkel Huinink; W J van der Vijgh; F J Bierhorst; A Lai; Otilia Dalesio; HERBERT PINEDO; Cindy Veenhof; Jos H Beijnen
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):317-29.
1996: R L Poorter; Fanny N Lauw; Willem A Bemelman; P J M Bakker; Carlo W Taat; Cindy Veenhof
Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy.
European journal of cancer (Oxford, England : 1990) 1996;32A(13):2262-6.
1996: Chris van Bree; RC Rietbroek; E M Schopman; JB Kipp; P J M Bakker
Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(II) on nonirradiated and preirradiated rat solid tumors.
International journal of radiation oncology, biology, physics 1996;36(1):135-40.
1996: Patricia Kaaijk; Dirk Troost; Onno J de Boer; P Van Amstel; P J M Bakker; Sieger Leenstra; D Andries Bosch
Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
British journal of cancer 1996;74(2):187-93.
1996: E M Schopman; Chris van Bree; P J M Bakker; JB Kipp; GW Barendsen
Hyperthermia-enhanced effectiveness of mitoxantrone in an experimental rat tumour.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1996;12(2):241-54.
1996: J M Stouthard; H Goey; E G de Vries; P H de Mulder; A Groenewegen; L Pronk; Gerrit Stoter; Hans P Sauerwein; P J M Bakker; C H Veenhof
Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.
British journal of cancer 1996;73(6):789-93.
1996: RC Rietbroek; P J M Bakker; Marten S Schilthuis; A J Postma; P J Zum Vörde Sive Vording; D Gonzalèz Gonzalèz; K H Kurth; A J Bakker; Cindy Veenhof
Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.
International journal of radiation oncology, biology, physics 1996;34(4):887-93.
1996: Chris van Bree; J J Krooshoop; RC Rietbroek; JB Kipp; P J M Bakker
Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor.
Cancer research 1996;56(3):563-8.
1996: R L Poorter; P J M Bakker; Paul Fockens; Carlo W Taat; Joep F W M Bartelsman; Cindy Veenhof
Intermittent continuous infusion of 5-fluorouracil in combination with epirubicin and cisplatin in advanced gastric cancer: the importance of dose intensity.
The Journal of infusional chemotherapy 1996;6(2):87-91.
1996: Chris van Bree; E M Schopman; P J M Bakker; JB Kipp; GW Barendsen
Local hyperthermic treatment does not enhance mitoxantrone effectiveness for responses of a rat solid tumour regrowing after irradiation.
Journal of cancer research and clinical oncology 1996;122(3):147-53.
1995: R L Poorter; P J M Bakker; manon huizing; Carlo W Taat; RC Rietbroek; Dirk J Gouma; Erik A J Rauws; Cindy Veenhof
Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(10):1048-9.
1995: Jaap Haveman; RC Rietbroek; A Geerdink; J Van Rijn; P J M Bakker
Effect of hyperthermia on the cytotoxicity of 2',2'-difluorodeoxycytidine (gemcitabine) in cultured SW1573 cells.
International journal of cancer. Journal international du cancer 1995;62(5):627-30.
1995: K M Hebeda; manon huizing; P A Brouwer; F W van der Meulen; H J Hulsebosch; Peter Reiss; J Oosting; Cindy Veenhof; P J M Bakker
Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(1):61-70.
1995: J M Stouthard; Johannes A Romijn; Tom van der Poll; Erik Endert; S Klein; P J M Bakker; C H Veenhof; Hans P Sauerwein
Endocrinologic and metabolic effects of interleukin-6 in humans.
The American journal of physiology 1995;268(5 Pt 1):E813-9.
1995: P Deprés-Brummer; M Itzhaki; P J M Bakker; F J Hoek; K H Veenhof; R de Wit
The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer.
Journal of cancer research and clinical oncology 1995;121(7):419-22.
1995: R L Poorter; Godefridus J Peters; P J M Bakker; Carlo W Taat; D M Biermans-van Leeuwe; Giovanni Codacci-Pisanelli; Paul Noordhuis; J Oosting; Cindy Veenhof
Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parameters.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1465-70.
1995: P J M Bakker; Sven A Danner; C H ten Napel; Frank P Kroon; Herman Sprenger; R van Leusen; Pieter L Meenhorst; A Muusers; Cindy Veenhof
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).
European journal of cancer (Oxford, England : 1990) 1995;31A(2):188-92.
1994: J M Stouthard; Tom van der Poll; Erik Endert; P J M Bakker; C H Veenhof; Hans P Sauerwein; Johannes A Romijn
Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans.
The Journal of clinical endocrinology and metabolism 1994;79(5):1342-6.
1994: R L Poorter; P J M Bakker; Carlo W Taat; Joep F W M Bartelsman; Cindy Veenhof
Epirubicin, cisplatin and intermittent continuous infusion of 5-fluorouracil in advanced gastric cancer: an effective regimen?
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1404.
1994: Jacob A Aten; Jan Stap; Ron A Hoebe; P J M Bakker
Application and detection of IdUrd and CldUrd as two independent cell-cycle markers.
Methods in cell biology 1994;41():317-26.
1993: R L Poorter; P J M Bakker; Carlo W Taat; Cindy Veenhof
Intermittent continuous intravenous infusion of 5-fluorouracil; a useful approach in disseminated colorectal cancer?
European journal of cancer (Oxford, England : 1990) 1993;29A(5):775.
1993: P J M Bakker; L J Tukker; Jan Stap; C H Veenhof; Jacob A Aten
Micronuclei expression in tumors as a test for radiation sensitivity.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;26(1):69-72.
1993: P J M Bakker; R J de Vries; C J Tukker; Ron A Hoebe; GW Barendsen
Application of a DNA double labelling method for the flow cytometric analysis of recruitment of non-cycling cells in a mixed population of P and Q cells.
Cell proliferation 1993;26(1):89-100.
1992: Jacob A Aten; P J M Bakker; Jan Stap; G A Boschman; C H Veenhof
DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication.
The Histochemical journal 1992;24(5):251-9.
1992: R de Wit; F J Hoek; P J M Bakker; Cindy Veenhof
A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(4):314-5.
1992: Cindy Veenhof; R de Wit; B G Taal; L Y Dirix; John Wagstaff; A Hensen; A C Huldij; P J M Bakker
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
European journal of cancer (Oxford, England : 1990) 1992;28(1):75-8.
1991: R de Wit; M H Raasveld; R J ten Berge; Pol A van der Wouw; P J M Bakker; Cindy Veenhof
Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alpha.
Journal of internal medicine 1991;229(6):539-42.
1991: R De Wit; F J Hoek; P J M Bakker; Cindy Veenhof
The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites.
Journal of internal medicine 1991;229(5):463-6.
1991: Thomas M van Gulik; Carlo W Taat; J F M Slors; J Bras; L E Blank; P J M Bakker; J G Kromhout; W H Brummelkamp
Leiomyosarcoma of large and small veins: clinical findings and results of treatment in six patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1991;17(2):125-34.
1991: P J M Bakker; Jan Stap; C J Tukker; C H van Oven; C H Veenhof; Jacob A Aten
An indirect immunofluorescence double staining procedure for the simultaneous flow cytometric measurement of iodo- and chlorodeoxyuridine incorporated into DNA.
Cytometry 1991;12(4):366-72.
1991: R de Wit; Sven A Danner; P J M Bakker; Joep M A Lange; J K Eeftinck Schattenkerk; Cindy Veenhof
Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma.
Journal of internal medicine 1991;229(1):35-40.
1990: R de Wit; W G Smit; K H Veenhof; P J M Bakker; F Oldenburger; D G González
Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;19(2):131-6.
1990: R de Wit; P J M Bakker; Sven A Danner; J Goudsmit; K H Veenhof
Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcoma.
International journal of STD & AIDS 1990;1(4):256-8.
1990: R de Wit; P J M Bakker; P Reiss; F J Hoek; Joep M A Lange; J Goudsmit; K H Veenhof
Temporary increase in serum beta 2-microglobulin during treatment with interferon-alpha for AIDS-associated Kaposi's sarcoma.
AIDS (London, England) 1990;4(5):459-62.
1990: R de Wit; P J M Bakker; K H Veenhof; Sven A Danner
Continued zidovudine and interferon-alpha therapy in Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)
Annals of internal medicine 1990;112(4):306-7.
1989: R de Wit; P Reiss; P J M Bakker; Joep M A Lange; Sven A Danner; K H Veenhof
Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma.
AIDS (London, England) 1989;3(12):847-50.
1989: P J M Bakker; Jacob A Aten; C J Tukker; GW Barendsen; C H Veenhof
Flow cytometric analysis of experimental parameters for the immunofluorescent labeling of BrdUrd in various tumour cell lines.
Histochemistry 1989;91(5):425-9.
1988: R de Wit; J K Schattenkerk; Charles A B Boucher; P J M Bakker; K H Veenhof; Sven A Danner
Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
Lancet 1988;2(8622):1214-7.
1988: P J M Bakker; Sven A Danner; Joep M A Lange; K H Veenhof
Etoposide for epidemic Kaposi's sarcoma: a phase II study.
European journal of cancer & clinical oncology 1988;24(6):1047-8.